Showing results (351-360 of 606) with videos related to

Sort By:
Pageof 61
Pharmacoeconomics - Open|October 17, 2018
Time and Cost of Hospitalisation for Salvage Therapy in Adults with Philadelphia Chromosome-Negative B Cell Precursor Relapsed or Refractory Acute Lymphoblastic Leukaemia in SpainBlanca Boluda, Rebeca Rodríguez-Veiga, David Martínez-Cuadrón, et al.
Pharmacoeconomics - Open|June 27, 2018
Influence of Idiopathic Pulmonary Fibrosis Progression on Healthcare Resource UseAlex Diamantopoulos, Toby M Maher, Nils Schoof, et al.
Pharmacoeconomics - Open|June 28, 2018
Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and RecommendationsJing Shen, Sarah Hill, David Mott, et al.
Pharmacoeconomics - Open|August 5, 2018
International HTA Experience with Targeted Therapy Approvals for Lung CancerFatma Maraiki, J Byrnes, H Tuffaha, et al.
Pharmacoeconomics - Open|April 7, 2018
Does Methodological Guidance Produce Consistency? A Review of Methodological Consistency in Breast Cancer Utility Value Measurement in NICE Single Technology AppraisalsMicah Rose, Stephen Rice, Dawn Craig
Pharmacoeconomics - Open|April 7, 2018
Economic Evaluation of Midazolam-Droperidol Combination, Versus Droperidol or Olanzapine for the Management of Acute Agitation in the Emergency Department: A Within-Trial AnalysisCelene Y L Yap, Ya-Seng Arthur Hsueh, Jonathan C Knott, et al.
Pharmacoeconomics - Open|April 7, 2018
Healthcare Resource Uses and Out-of-Pocket Expenses Associated with Pulmonary TB Treatment in ThailandPimwara Tanvejsilp, Mark Loeb, Jonathan Dushoff, et al.
Pharmacoeconomics - Open|April 7, 2018
The Potential Clinical and Economic Value of Primary Tumour Identification in Metastatic Cancer of Unknown Primary Tumour: A Population-Based Retrospective Matched Cohort StudyMalek B Hannouf, Eric Winquist, Salaheddin M Mahmud, et al.
Pharmacoeconomics - Open|April 7, 2018
Out-of-Pocket Expenditures, Indirect Costs and Health-Related Quality of Life of Patients with Pulmonary Tuberculosis in ThailandPimwara Tanvejsilp, Mark Loeb, Jonathan Dushoff, et al.
Pharmacoeconomics - Open|June 20, 2018
Cost Effectiveness of Long-Term Incobotulinumtoxin-A Treatment in the Management of Post-stroke Spasticity of the Upper Limb from the Australian Payer PerspectiveKoji Makino, Dominic Tilden, Carmel Guarnieri, et al.
Pageof 61